Immunogen reported $-24145000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 4490M 446M
Agios Pharmaceuticals AGIO:US $ -94.77M 0.15M
Amgen AMGN:US $ 1476M 423M
Astellas Pharma 4503:JP Y -8408M 69294M
AstraZeneca AZN:LN 386M 733M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Emergent Biosolutions EBS:US $ -3.7M 193M
Exelixis EXEL:US $ 68.57M 26.59M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Immunogen IMGN:US $ -24.14M 13.03M
Intrexon XON:US $ -19.25M 5.78M
Karyopharm Therapeutics KPTI:US $ -41399000 80.12M
Macrogenics MGNX:US $ -66.44M 8.42M
Nektar Therapeutics NKTR:US $ -90.39M 55.25M
Novartis NVS:US $ 2222M 14086M
Pfizer PFE:US $ 7863M 4470M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M
Seattle Genetics SGEN:US $ -136.49M 38.13M